ACADIA PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.25 USD | +1.47% |
|
+3.23% | -44.91% |
| Apr. 30 | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
| Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Other Biotechnology & Medical Research | +1.47% | +3.23% | -44.91% | -21.34% | -33.17% | 2.85B |  |  | |
- Stock Market
- Equities
- ACAD Stock
- Charts ACADIA Pharmaceuticals Inc.
- Relative Strength Chart